| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated treatment of endocarditis—The POET II trial: Rationale and design of a randomized controlled trial
|
Østergaard, Lauge
|
|
|
227 |
C |
p. 40-46
|
artikel
|
| 2 |
A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry
|
Joseph, Philip
|
|
|
227 |
C |
p. 56-63
|
artikel
|
| 3 |
A randomized controlled trial of lung ultrasound-guided therapy in heart failure (CLUSTER-HF study)
|
Araiza-Garaygordobil, Diego
|
|
|
227 |
C |
p. 31-39
|
artikel
|
| 4 |
China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial
|
Xu, Yi
|
|
|
227 |
C |
p. 47-55
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
227 |
C |
p. iv
|
artikel
|
| 6 |
Exploring payments in the US pharmaceutical market from 2011 to 2019: Update on pharmacy benefit manager impact
|
Weinstein, Emery P.
|
|
|
227 |
C |
p. 107-110
|
artikel
|
| 7 |
Information for Readers
|
|
|
|
227 |
C |
p. v
|
artikel
|
| 8 |
Modifiable lifestyle factors and heart failure: A Mendelian randomization study
|
van Oort, Sabine
|
|
|
227 |
C |
p. 64-73
|
artikel
|
| 9 |
North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) registry: Rationale, design, and implications
|
Dehghani, Payam
|
|
|
227 |
C |
p. 11-18
|
artikel
|
| 10 |
Percutaneous complete revascularization strategies using sirolimus-eluting biodegradable polymer-coated stents in patients presenting with acute coronary syndrome and multivessel disease: Rationale and design of the BIOVASC trial
|
den Dekker, Wijnand K.
|
|
|
227 |
C |
p. 111-117
|
artikel
|
| 11 |
Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: A meta-analysis of randomized trials
|
Kuno, Toshiki
|
|
|
227 |
C |
p. 9-10
|
artikel
|
| 12 |
P2Y12 inhibitor monotherapy versus aspirin monotherapy after short-term dual antiplatelet therapy for percutaneous coronary intervention: Insights from a network meta-analysis of randomized trials
|
Kuno, Toshiki
|
|
|
227 |
C |
p. 82-90
|
artikel
|
| 13 |
Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial
|
Biagioni, Rodrigo Bruno
|
|
|
227 |
C |
p. 100-106
|
artikel
|
| 14 |
Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve
|
Jawitz, Oliver K.
|
|
|
227 |
C |
p. 91-99
|
artikel
|
| 15 |
Rationale and design of the RIGHT trial: A multicenter, randomized, double-blind, placebo-controlled trial of anticoagulation prolongation versus no anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
|
Yan, Yan
|
|
|
227 |
C |
p. 19-30
|
artikel
|
| 16 |
Table of Contents
|
|
|
|
227 |
C |
p. i-iii
|
artikel
|
| 17 |
The cardiac intensive care unit and the cardiac intensivist during the COVID-19 surge in New York City
|
Anstey, D. Edmund
|
|
|
227 |
C |
p. 74-81
|
artikel
|
| 18 |
The utility of risk scores when evaluating for acute myocardial infarction using high-sensitivity cardiac troponin I
|
Gibbs, Joseph
|
|
|
227 |
C |
p. 1-8
|
artikel
|
Tijdschrift beschrijving